Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Kennedy launches abortion pill review
Health and Wellness

Kennedy launches abortion pill review

Last updated: September 26, 2025 6:51 am
Share
Kennedy launches abortion pill review
SHARE

Stay informed about the latest in health and medicine each weekday by subscribing to STAT’s free newsletter, Morning Rounds. Sign up here.

This week has been a whirlwind in the realm of disability coverage. On Wednesday, after a long day writing my third article within the span of three days, I suddenly realized I hadn’t eaten and, in a moment of desperation, grabbed a two-liter bottle of Sunkist. The sugar hit my empty stomach like a freight train, nearly sending me over the edge.

As a side note, we’re running a special ten-year anniversary subscription promotion that’s ending soon. Consider subscribing! Your support not only sustains our award-winning journalism but also fuels my orange soda habit.

Kennedy and Makary Initiate Fresh Review of Mifepristone

Officials are urging the Food and Drug Administration (FDA) to reassess the safety profile of mifepristone, an abortion-inducing medication.

Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary recently sent a letter to state attorneys general, highlighting reports of “serious adverse events” associated with mifepristone use. The FDA intends to review existing evidence to ensure that women’s health remains protected by thoroughly examining the guidelines for when mifepristone can be dispensed safely.

Numerous studies have substantiated the effectiveness and safety of mifepristone, including research on its administration at home versus in clinical settings. Most recently, in 2023, the Risk Evaluation and Mitigation Strategy was amended to abolish the necessity of in-person authorization, which has significantly improved access for individuals living far from healthcare facilities.

Insights on Indirect Costs: Changes in Federal Research Support

At STAT, we continuously investigate the implications of indirect costs in research, which encompass essential expenses such as building upkeep and support staff salaries that are vital for sustaining biomedical discoveries.

See also  Salesforce launches Agentforce 2dx, letting AI run autonomously across enterprise systems

Recent discussions have emerged surrounding the Trump administration’s and Congress’s desire to drastically cut funding for these indirect costs at prestigious universities and research institutions. STAT’s Jonathan Wosen interviewed Gil Tran, a former Office of Management and Budget official who was instrumental in developing a government-wide framework for grant management.

For those affiliated with academic or research institutions, staying informed on the expected changes regarding indirect cost funding is crucial. I highly recommend reading Jonathan’s piece, which contains valuable insights from Tran about how federal negotiations on indirect cost rates could evolve.

Imagining a Smaller NIH: A Thought Experiment

A group of four researchers published a compelling thought experiment in Science this week, exploring a scenario where the NIH’s budget had always been 40% lower.

Considering the landscape since the beginning of the year, new and competitive grants at the NIH have plummeted over 40% compared to the previous 12 months. The researchers analyzed potential outcomes of this reduced funding on the development of vital medications, recognizing that the path to market approval for new treatments can span decades.

The study suggested that significant drugs, including a treatment for leukemia and one for type 1 Gaucher disease, would likely have not made it to market under such constraints. They noted that nearly 12% of new drug approvals since the year 2000 are directly linked to research that would not have been funded at reduced levels. For more details, click here.

Escalating Ebola Outbreak in Congo

Southern Congo is grappling with a severe Ebola outbreak, with numerous fatalities reported. Since the outbreak’s announcement on September 4th, 2025, the World Health Organization has recorded nearly 60 cases and 35 deaths, resulting in a fatality rate exceeding 61%. The lone treatment facility in the region is overwhelmed, and aid organizations are striving to secure additional funding for containment efforts. Health officials express concern that cuts to U.S. funding may hinder these initiatives, given the historical support for Congo’s public health programs.

See also  Microsoft Unveils A New Class Of Quantum Chip

This marks my third report highlighting this troubling situation, and I sincerely hope that future updates will bring more positive developments. For ongoing coverage, find more here.

Concerns Grow Over Access to Gender-Affirming Care

Recently, ongoing anti-trans narratives and policies from President Trump and other officials have contributed to rising concerns among Americans regarding their future access to gender-affirming care, as reported by a recent poll conducted by The 19th and Survey Monkey.

In just a year, the percentage of Americans fearing increased restrictions on this essential care has surged from 20% to nearly 40%, according to a survey of over 20,000 U.S. residents conducted in September.

Despite the scientific consensus among major medical organizations that gender-affirming care is critical and potentially life-saving for transgender individuals, many politicians remain unconvinced. Currently, 40% of trans youth reside in states that have enacted legislation limiting access to gender-affirming care—a statistic that is likely to increase, particularly given new policies being discussed by the Trump administration.

Noteworthy Reads

  • Meet Stefanie Spear, closely associated with RFK Jr. in HHS, Vanity Fair.
  • The intriguing narrative of DOGE as recounted by federal workers, WIRED.
  • An estimated 1.4 million lawfully present immigrants are set to lose health coverage due to the 2025 tax and budget law, KFF.
  • RFK Jr.’s team aimed to promote an autism therapy but chose to target Tylenol instead, Wall Street Journal.
  • The Pentagon has introduced exemptions concerning flu shot requirements for all service members, AP.

Contents
Kennedy and Makary Initiate Fresh Review of MifepristoneInsights on Indirect Costs: Changes in Federal Research SupportImagining a Smaller NIH: A Thought ExperimentEscalating Ebola Outbreak in CongoConcerns Grow Over Access to Gender-Affirming CareNoteworthy Reads

This rewritten article maintains the original HTML structure and key points while offering fresh phrasing and perspectives suitable for a WordPress platform.

See also  Robert F. Kennedy Jr.’s Policies Could Exacerbate Health Inequities
TAGGED:abortionKennedyLaunchespillreview
Share This Article
Twitter Email Copy Link Print
Previous Article Weezer bassist’s wife Jillian Shriner to attend 2-year mental health program after firing at LAPD cops Weezer bassist’s wife Jillian Shriner to attend 2-year mental health program after firing at LAPD cops
Next Article Career criminal gets 6 years for robbing musician of ,000 violin in the Loop – CWB Chicago Career criminal gets 6 years for robbing musician of $10,000 violin in the Loop – CWB Chicago
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Who Was Diogo Jota? What To Know After His Tragic Death At 28

The Legacy of Diogo Jota: A Brief Career Remembered Diogo Jota left behind a relatively…

July 8, 2025

Actress Sophie Nyweide Dead Aged 24 — Mom Claims ‘She Was Using Drugs’

Sophie Nyweide, a talented actress known for her roles in films such as "Mammoth," "An…

April 22, 2025

Rollout of new tools to curb RSV expected to be smoother this year

For Beyfortus, the timing is also crucial. The injection has to be given to infants…

October 5, 2024

Don’t make the mistake we did in San Francisco by electing Zohran Mamdani

San Francisco's cautionary tale: A warning for New Yorkers As New Yorkers, we must take…

June 27, 2025

EU Reverses Course and Is Now Willing to Renegotiate Trade Deal with US |

EU Suspends Retaliatory Tariffs: A Temporary Truce with Trump? On the previous Thursday, the European…

April 15, 2025

You Might Also Like

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown
Health and Wellness

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown

October 10, 2025
Apple’s ‘The Last Frontier’ Is a Zany Alaska Thriller That Gets Bogged Down by a Generic Espionage Plot: TV Review
Entertainment

Apple’s ‘The Last Frontier’ Is a Zany Alaska Thriller That Gets Bogged Down by a Generic Espionage Plot: TV Review

October 10, 2025
No, circumcision doesn’t cause autism
Health and Wellness

No, circumcision doesn’t cause autism

October 10, 2025
Jay Shetty and his health advice are everywhere. It’s by design
Health and Wellness

Jay Shetty and his health advice are everywhere. It’s by design

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?